The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of flibanserin on libido in women with breast cancer on adjuvant endocrine therapy.
 
Shari Beth Goldfarb
Stock and Other Ownership Interests - Rejoy Inc
Consulting or Advisory Role - Ms. Medicine; NanOlogy; Revision Skincare; Sermonix Pharmaceuticals; Shook, Hardy, Bacon LLP; TerSera
Research Funding - Paxman; Sprout Pharmaceuticals
 
Jeanne Carter
Research Funding - Sprout Pharmaceuticals (Inst); Sprout Pharmaceuticals (Inst)
 
Ashley Arkema
No Relationships to Disclose
 
Margaret Cheng
No Relationships to Disclose
 
Nadia Abdo
No Relationships to Disclose
 
George F. Zahrah
No Relationships to Disclose
 
Elaina Vicari
No Relationships to Disclose
 
Samantha Santovasi
No Relationships to Disclose
 
Analisa Dacunto
No Relationships to Disclose
 
Cassandra Chang
No Relationships to Disclose
 
Linda T. Vahdat
Honoraria - Osmol Therapeutics; polyphor; Seagen
Consulting or Advisory Role - Berg Pharma; Depymed
Research Funding - Genentech/Roche (Inst); Immunomedics (Inst); Polyphor (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - we have a patent pending on the application for BMD progenitor cells (Inst)